Company Overview

Company Name

HEALIOS K.K.

Representative

Hardy TS Kagimoto, MD, Chairman and CEO

Establishment

February 24, 2011

Paid in Capital

2,800million yen (As of Mar. 31, 2024)

Head Office

Hibiya Mitsui Tower 12F, WORK STYLING, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo 100-0006, Japan

Number of Employees

60 (As of Mar. 31, 2024)

Business

Research, development and manufacturing of cell therapy/ regenerative medicine products

Research Institution

Kobe Research Institute

Affiliated Company

Sighregen Co., Ltd.
(Joint Venture with Sumitomo Pharma Co., Ltd.)

Subsidiaries

・Healios NA Inc.
(Established in February 2018)
・Saisei Ventures LLC
(Established in January 2021 as a venture fund investment advisor)
・Saisei Capital Ltd.
(Established in January 2021 as a venture fund general partner)
・Saisei Bioventures, L.P.
(Established in January 2021 as a venture fund limited partnership)
・ProcellCure Inc.(Established in July 2023 to promote development of ARDS)
・eNK Therapeutics Inc.(Established in August 2023 to promote R&D of eNK cells)

Access

Tokyo Office

Address
Hibiya Mitsui Tower 12F, WORK STYLING, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo 100-0006, Japan

Chiyoda Line

Hibiya Line

Mita Line

Direct access from Hibiya Station (subway)

JR Yamanote Line

JR Keihin Tohoku Line

Yurakucho Line

5-minute walk from Yurakucho Station

Kobe Research Institute

Address
Kobe KIMEC Center Bldg. 3F 1-5-2 Minatojima-Minamimachi Chuo-ku, Kobe, Hyogo 650-0047

Port Liner Monorail

2-minute walk from Iryo Center Station